The ‘top 100’ drugs and classes in England: an updated ‘starter formulary’ for trainee prescribers
Aims Prescribing is a complex skill required of doctors and, increasingly, other healthcare professionals. Use of a personal formulary can help to develop this skill. In 2006–9, we developed a core list of the 100 most commonly prescribed drugs. Our aim in the present study was to update this ‘start...
Gespeichert in:
Veröffentlicht in: | British journal of clinical pharmacology 2018-11, Vol.84 (11), p.2562-2571 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Aims
Prescribing is a complex skill required of doctors and, increasingly, other healthcare professionals. Use of a personal formulary can help to develop this skill. In 2006–9, we developed a core list of the 100 most commonly prescribed drugs. Our aim in the present study was to update this ‘starter formulary’ to ensure its continued relevance for prescriber training.
Methods
We analysed large contemporary primary and secondary care datasets to identify the most frequently prescribed medicinal products. Items were classified into natural groups, broadly following their British National Formulary classification. The resulting drug groups were included in the core list if they comprised ≥0.1% prescriptions in both settings or ≥0.2–0.3% prescriptions in one setting. Drugs from emergency guidelines that did not qualify by prescribing frequency completed the list.
Results
Over 1 billion primary care items and approximately 1.8 million secondary care prescriptions were analysed. The updated list comprises 81 drug groups commonly prescribed in both settings; six from primary care; seven from secondary care; and six from emergency guidelines. Eighty‐eight per cent of the formulary was unchanged. Notable changes include entry of newer anti‐epileptics and dipeptidyl peptidase‐4 inhibitors and exit of phenytoin and thiazolidinediones.
Conclusions
The relative stability of the core drug list over 9 years and the current update ensure that learning based on this list remains relevant to practice. Trainee prescribers may be encouraged to use this ‘starter formulary’ to develop a sound basis of prescribing knowledge and skills that they can subsequently apply more widely. |
---|---|
ISSN: | 0306-5251 1365-2125 |
DOI: | 10.1111/bcp.13709 |